Similarly, another study that also found increased NSD2 expression with prostate cancer progression demonstrated that high NSD2 expression was positively correlated with the infiltration level of CD4+tumor-infiltrating lymphocytes (TILs) and negatively correlated with that of CD8+TILs [48]. Here, NSD2 is linked to prostate cancer.